Clinical Trials
Study Title:
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Sterotactic Radiotherapy in Recurrent Glioblastoma
|
For more information about the trial above please contact the study team:
Principal Investigator, Alicia Zukas, at zukas@musc.edu.
Study Coordinator, Alexandra Leitner, at leitnera@musc.edu, or please call +1 843-792-1507.
|